Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients

Summary

Takayasu arteritis (TAK) is a rare chronic inflammatory arteritis, which lacks an effective well-accepted intervention strategy. Here we tried to classify TAK patients in 3 levels, including mild, moderate, and severe, and prescribe methotrexate and tofacitinib randomly in mild and moderate patients, to observe the relatively better treatment strategy, facilitating better intervention strategy in TAK patients.

Timeline

Start

2020-03-01

Primary completion

2022-12-31

Completion

2023-12-31

Drugs

Indications